Prochlorperazine for nausea and vomiting accompanied COVID-19

J Gastroenterol Hepatol. 2021 Feb;36(2):524-525. doi: 10.1111/jgh.15301. Epub 2020 Nov 3.

Authors

C S Kow¹, S S Hasan^{2

3}

Affiliations

¹ School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
² Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom.
³ School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia.

PMID: 33068035
DOI: 10.1111/jgh.15301

No abstract available

Publication types

Letter

MeSH terms

Antiemetics / therapeutic use*
COVID-19 / complications*
Humans
Nausea / drug therapy*
Nausea / virology
Prochlorperazine / therapeutic use*
Vomiting / drug therapy*
Vomiting / virology

Substances

Antiemetics
Prochlorperazine